Process for inhibiting herpes simplex virus-specified thymidine kinase
摘要
The invention relates to a method of selectively inhibiting herpes simplex virus-specified thymidine kinase. The method comprises exposing mammalian cells infected with the virus to an effective amount of 5'-ethynylthymidine. The invention further relates to a pharmaceutical composition comprising 5'-ethynylthymidine as the active ingredient together with a pharmaceutically acceptable carrier.
申请公布号
US5008252(A)
申请公布日期
1991.04.16
申请号
US19870028507
申请日期
1987.03.20
申请人
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL;HEALTH RESEARCH, INC.